001451087 000__ 06410cam\a2200565\i\4500
001451087 001__ 1451087
001451087 003__ OCoLC
001451087 005__ 20230310004642.0
001451087 006__ m\\\\\o\\d\\\\\\\\
001451087 007__ cr\cn\nnnunnun
001451087 008__ 221111s2022\\\\si\a\\\\o\\\\\001\0\eng\d
001451087 019__ $$a1350689928
001451087 020__ $$a9789811926556$$q(electronic bk.)
001451087 020__ $$a9811926557$$q(electronic bk.)
001451087 020__ $$z9789811926549
001451087 020__ $$z9811926549
001451087 0247_ $$a10.1007/978-981-19-2655-6$$2doi
001451087 035__ $$aSP(OCoLC)1350615576
001451087 040__ $$aYDX$$beng$$erda$$epn$$cYDX$$dGW5XE$$dEBLCP$$dOCLCF$$dOCLCQ
001451087 049__ $$aISEA
001451087 050_4 $$aQH588.S83
001451087 08204 $$a616.02/774$$223/eng/20221122
001451087 24500 $$aHandbook of stem cell therapy.$$nVolume 1 /$$cKhawaja Husnain Haider, editor.
001451087 264_1 $$aSingapore :$$bSpringer,$$c[2022]
001451087 264_4 $$c©2022
001451087 300__ $$a1 online resource (xxxi, 1526 pages) :$$billustrations (chiefly color)
001451087 336__ $$atext$$btxt$$2rdacontent
001451087 337__ $$acomputer$$bc$$2rdamedia
001451087 338__ $$aonline resource$$bcr$$2rdacarrier
001451087 500__ $$aIncludes index.
001451087 5050_ $$aIntro -- Foreword -- Contents -- About the Editor -- Section Editors -- Contributors -- Part I: Cell-Based Therapy Approach: Mesenchymal Stem Cell-Based Therapy -- 1 Human Mesenchymal Stem Cells: The Art to Use Them in the Treatment of Previously Untreatable -- Introduction -- Mesenchymal Stem Cells Current Status: The ``Problems ́́That in Reality Do Not Exist -- Practical Approaches: The Golden Standards, i.e., ``Good Biological Praxis ́́(GBP) Using the Historical Laboratory Experience -- Data Extrapolation from Small Animal Studies to Humans Is Unfounded and Without Relevance
001451087 5058_ $$aCurrent Research Paradigm: MSCs in Advanced Phases of Clinical Trials Although Understandable Is Far from Personalized Medicine -- A Case of Autologous Versus Allogeneic MSCs, an Unanswered Question -- A Case for Autologous Cells -- Autologous Cells from Patients Are Also ``sick ́́ -- Autologous Cells in Elderly Patients Are Also Aged -- A Case for Allogeneic Cells -- Logistic Advantage of Allogenic MSCs -- Allogenic MSCs Overcome the Limitations of Aging and Sickness of Autologous Cells -- Quality Control of MSCs Preparation: A Prerequisite for Optimal Prognosis -- Conclusion -- References
001451087 5058_ $$a2 Sources and Therapeutic Strategies of Mesenchymal Stem Cells in Regenerative Medicine -- Introduction -- Mesenchymal Stem Cells -- Sources of Mesenchymal Stem Cells -- Bone Marrow-Derived MSCs -- Advantages of BM-Derived MSCs -- Limitations of BM-Derived MSCs -- Adipose Tissue-Derived MSCs -- Advantages of Adipose Tissue-Derived MSCs -- Limitations of Adipose Tissue-Derived MSCs -- Isolation of Adipose Tissue-Derived MSCs -- Clinical Applications of Adipose Tissue-Derived MSCs -- Umbilical Cord-Derived MSCs -- Human Umbilical Cord Structure and Function -- Advantages of WJ-Derived MSCs
001451087 5058_ $$aLimitations of WJ-Derived MSCs -- Isolation Methods of WJ-Derived MSCs -- Clinical Applications of WJ-Derived MSCs -- Therapeutic Strategies of Using MSCs -- Tissue Regeneration -- Immunomodulation of MSCs -- Extracellular Vesicles/Exosomes Derived from MSCs -- MSCs Act as an Efficient Tool for Gene Therapy -- References -- 3 Considerations for Clinical Use of Mesenchymal Stromal Cells -- Introduction -- Biological Characteristics -- Phenotypic Profile -- MSCs ́Proliferation -- Differentiation Capacity -- Cellular Transformation -- Mechanism of Action -- Cell Migration Toward Damaged Tissues
001451087 5058_ $$aTissue Repair -- Immunomodulatory Potential -- Preclinical Applications -- MSC-Based Therapy for Autoimmune Diseases -- MSCs for Cancer Treatment -- The Anti-tumor Activity of MSCs -- The Pro-tumor Activity of MSCs -- The Imprint of Disease on MSCs -- Considerations for Clinical Applications -- Safety Concerns -- Cell Manufacturing for Clinical Use -- Considerations for Cellular Medicament -- General Considerations -- Attempts to Improve the Therapeutic Outcomes of Cellular Medicament -- Concluding Remarks and Future Perspective -- Cross-References -- References
001451087 506__ $$aAccess limited to authorized users.
001451087 520__ $$aThe handbook comprehensively reviews the therapeutic potential of stem cells and stem cell secretome-based cell-free strategies in regenerative medicine. The chapters in section I and section II respectively discuss the diverse applications of mesenchymal stem cells and non- mesenchymal stem cells, including skeletal myoblasts, endothelial progenitor cells, adipose tissue-derived stem cells, induced pluripotent stem cells, and neuronal stem cells in myocardial repair, inflammatory bowel disease, cognitive deficits, wound healing, retinal disorders, and COVID-19. The subsequent chapters in section IIIprimarily focused on the fast-emerging cell-free therapy approach in regenerative medicine for tissue repair and regeneration. These chapters review the impact of stem cell-derived secretome on various biological processes such as angiogenesis, neurogenesis, tissue repair, immunomodulation, musculoskeletal pathologies, wound healing, anti-fibrotic, and anti-tumorigenesis for tissue maintenance and regeneration.Lastly, section IV summarizes miscellaneous aspects of cell-based therapy, includingthe treatment advantages, opportunities, and shortcomings in stem cell-based therapy, potentially helping to refine future studies and translate them from experimental to clinical studies. Moreover, this section also has chapters on cancer stem cells as novel targets in cancer therapeutics. This Major Reference Book (MRW) is a valuable resource for researchers involved in stem cell research to understand the multifaceted therapeutic applications of stem cells and their derivative secretome in regenerative medicine.
001451087 588__ $$aOnline resource; title from PDF title page (SpringerLink, viewed November 22, 2022).
001451087 650_0 $$aStem cells$$xTherapeutic use.
001451087 650_0 $$aStem cells$$xTransplantation.
001451087 650_0 $$aRegenerative medicine.
001451087 655_0 $$aElectronic books.
001451087 7001_ $$aHaider, Khawaja Husnain,$$eeditor.
001451087 77608 $$iPrint version: $$z9811926549$$z9789811926549$$w(OCoLC)1309867275
001451087 852__ $$bebk
001451087 85640 $$3Springer Nature$$uhttps://univsouthin.idm.oclc.org/login?url=https://link.springer.com/10.1007/978-981-19-2655-6$$zOnline Access$$91397441.1
001451087 909CO $$ooai:library.usi.edu:1451087$$pGLOBAL_SET
001451087 980__ $$aBIB
001451087 980__ $$aEBOOK
001451087 982__ $$aEbook
001451087 983__ $$aOnline
001451087 994__ $$a92$$bISE